Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Zsolt Illes

Professor

University Name

Denmark

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

30%

Neurology

100%

Multiple Sclerosis

50%

Autoimmunity

40%

Neurological Disorder

40%

Inflammatory Biology

20%

Medical Statistics

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Contribution of aging to progressive and smouldering pathology in multiple sclerosis

Open Date: 2024-01-01

Close Date: 2025-01-01

Grant: Close

B CELL DEPLETION IN MULTIPLE SCLEROSIS: MECHANISM & RELATION TO OUTCOMES IN A PHASE 3 CLINICAL TRIAL

Open Date: 2022-03-01

Close Date: 2024-03-01

Grant: Close

The brain grey matter in SPMS: epigenetic drive behind progression

Open Date: 2020-09-01

Close Date: 2021-09-01

Grant: Close

Astrocyte-related repair versus damage in the brain of patients with progressive multiple sclerosis

Open Date: 2019-07-01

Close Date: 2022-07-01

Grant: Close

Epigenetic control and viral gene activation in the brain of patients with secondary progressive multiple sclerosis

Open Date: 2018-01-01

Close Date: 2018-12-01

Articles19

Socioeconomic burden of AQP4-antibody seropositive NMOSD: a nationwide registry-based study

Article Link

Year:

2024

Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study

Article Link

Year:

2024

Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis Optica Spectrum Disorder Patient Cohort

Article Link

Year:

2024

Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy

Article Link

Year:

2024

Patterns and predictors of multiple sclerosis phenotype transition

Article Link

Year:

2024

Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis

Article Link

Year:

2024

Single-Cell Multi-Omics Map of Cell Type–Specific Mechanistic Drivers of Multiple Sclerosis Lesions

Article Link

Year:

2024

Treatment of relapsing multiple sclerosis in Hungary - consensus recommendation from the Hungarian neuroimmunology society.

Article Link

Year:

2023

Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial.

Article Link

Year:

2023

Application of diagnostic criteria for optic neuritis - Authors' reply.

Article Link

Year:

2023

Paraneoplastic Kelch-like protein 11 antibody-associated cerebellar and limbic encephalitis caused by metastatic "burned-out" seminoma - A scar(r)y phenomenon.

Article Link

Year:

2023

Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes.

Article Link

Year:

2023

New Enhancing MRI Lesions Associate with IL-17, Neutrophil Degranulation and Integrin Microparticles: Multi-Omics Combined with Frequent MRI in Multiple Sclerosis

Article Link

Year:

2023

Plasma Exchange versus Intravenous Immunoglobulin in Worsening Myasthenia Gravis: A Systematic Review and Meta-Analysis with Special Attention to Faster Relapse Control

Article Link

Year:

2023

Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapy.

Article Link

Year:

2022

Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation.

Article Link

Year:

2022

Investigation of oxidative stress in patients with multifocal motor neuropathy.

Article Link

Year:

2022

Diagnosis and classification of optic neuritis.

Article Link

Year:

2022

Regaining Autonomy in a Holding Environment: Patients' Perspectives on the Existential Communication with Physicians When Suffering from a Severe, Chronic Illness: A Qualitative Nordic Study.

Article Link

Year:

2022

Collaborators22

Nasrin Asgari

Professor

University of Southern Denmark

DENMARK

Tobias Sejbaek

University of Southern Denmark

DENMARK

Finn Sellebjerg

Professor

Copenhagen University Hospital

DENMARK

Helle Hvilsted Nielsen

University of Southern Denmark

DENMARK

Kirsten Kaya Roessler

University of Southern Denmark

DENMARK

Richard Röttger

University of Southern Denmark

DENMARK

Alexandra Csongor

senior lecturer, head of English for Biomedical Purposes

University of Pécs, Medical School

HUNGARY

Jørgen T. Lauridsen

University of Southern Denmark

DENMARK

Peter Vestergaard Rasmussen

Associate professor

Aarhus University

DENMARK

Jesper B Moeller

University of Southern Denmark

DENMARK

Thorsten Bartsch

Professor

Christian-Albrechts-Universität zu Kiel

GERMANY

Maarten Titulaer

Erasmus University Rotterdam

NETHERLANDS

Maria José Sá

Universidade da Beira Interior Faculdade de Ciências da Saúde

PORTUGAL

Christopher Aboo

Aalborg University

DENMARK

Melinda Magyari

Associate professor

University of Copenhagen

DENMARK

Bernardo F. Sanchez-Dalmau

Hospital Clínic de Barcelona

SPAIN

Lasse Frank Voss

Technical University of Denmark

DENMARK

Zsolt Molnar

Professor

Semmelweis University

HUNGARY

Malene Møller Jørgensen

Aalborg University

DENMARK

Svend Geertsen

Københavns Universitet

DENMARK

Kirsten Hyrlov

University of Southern Denmark

DENMARK

Ichiro Nakashima

Professor

Tohoku Medical and Pharmaceutical University

JAPAN

How do I reach out?

Meet Kite AI